APIMEDS PHARMACEUTICALS US, INC. Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments of -$48.28 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-26.
Financial Statements › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 · last filed 2026-05-26
- APIMEDS PHARMACEUTICALS US, INC. change in unrealized gain (loss) on fair value hedging instruments for the quarter ending 2026-03-31 was -$48.28K.
| Period end | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 3 month |
|---|---|
| 2026-03-31 | -$48.28K 10-Q · filed 2026-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |